"A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer" by Kathryn Mittauer

Article

A Multi-Institutional Phase II Trial of Ablative 5-Fraction Stereotactic MR-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

International Journal of Radiation Oncology, Biology, Physics

Kathryn Mittauer, Miami Cancer Institute
Michael Chuong, Miami Cancer Institute

Find in your library

Publication Date

11-15-2023

Content Type

Article

PubMed ID:

37210048

Additional Authors:

Additional authors and institutional affiliations

Citation Information

International Journal of Radiation Oncology, Biology, Physics (2023) 117(4):799-808